Profile Image
Stuart Johnson Photo
Name
Stuart Johnson
Degree
M.D.
FIDSA
DTM&H
Rank
Professor
Primary Department
Infectious Disease
Appointment Request
Request an Appointment
Specialties
Clostridium Difficile Infection
General Infectious Disease
Infection Complications in Surgery
Travel-Related Infection
Tuberculosis (TB)
Locations
Loyola Outpatient Center
Certifications
Infectious Disease, American Board of Internal Medicine Subspecialty
American Board of Internal Medicine
Education
Medical School
University of Minnesota Medical School
Residencies
University of Minnesota Hospital and Clinics, Internal Medicine: General
Fellowships
University of Minnesota Hospital and Clinics/VA Medical Center, Minneapolis, Infectious Diseases
Hobbies
Foreign movies
Travel
Biking
Publications
Burns,L. J.; Abbetti,B.; Arnold,S. D.; Bender,J.; Doughtie,S.; El-Jawahiri,A.; Gee,G.; Hahn,T.; Horowitz,M. M.; Johnson,S.; Juckett,M.; Krishnamurit,L.; Kullberg,S.; LeMaistre,C. F.; Loren,A.; Majhail,N. S.; Murphy,E. A.; Rizzo,D.; Roche-Green,A.; Saber,W.; Schatz,B. A.; Schmit-Pokorny,K.; Shaw,B. E.; Syrjala,K. L.; Tierney,D. K.; Ullrich,C.; Vanness,D. J.; Wood,W. A.; Denzen,E. M.Engaging Patients in Setting a Patient-Centered Outcomes Research Agenda in Hematopoietic Cell Transplantation Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2018 ; :
Weaver,F. M.; Trick,W. E.; Evans,C. T.; Lin,M. Y.; Adams,W.; Pho,M. T.; Bleasdale,S. C.; Mullane,K. M.; Johnson,S.; Sikka,M. K.; Peterson,L. R.; Solomonides,A. E.; Gerding,D. N.The Impact of Recurrent Clostridium difficile Infection on Patients' Prevention Behaviors INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 2017 ;38(11):1351-1357
Johnson,S.Potential Risks and Rewards With Prophylaxis for Clostridium difficile Infection Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2016 ; :
von Eichel-Streiber,A.; Paik,W.; Knight,K.; Gisch,K.; Nadjafi,K.; Decker,C.; Bosnjak,O.; Cheknis,A.; Johnson,S.; von Eichel-Streiber,C.Induction of antitoxin responses in Clostridium-difficile-infected patients compared to healthy blood donors Anaerobe 2016 ; :
Sambol,S. P.; Johnson,S.; Gerding,D. N.Restriction Endonuclease Analysis Typing of Clostridium difficile Isolates Methods in molecular biology (Clifton, N.J.) 2016 ;1476:1-13
Scardina,T.; Labuszewski,L.; Pacheco,S. M.; Adams,W.; Schreckenberger,P.; Johnson,S.Clostridium difficile Infection (CDI) Severity and Outcome among Patients Infected with the NAP1/BI/027 Strain in a Non-Epidemic Setting INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY 2015 ;36(3):280-286
Goldstein,E. J.; Johnson,S.; Maziade,P. J.; McFarland,L. V.; Trick,W.; Dresser,L.; Millette,M.; Mazloum,H.; Low,D. E.Pathway to Prevention of Nosocomial Clostridium difficile Infection Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 ;60 Suppl 2:S148-58
Soriano,M. M.; Johnson,S.Treatment of Clostridium Difficile Infections INFECTIOUS DISEASE CLINICS OF NORTH AMERICA 2015 ;29(1):93-108
Evans,C. T.; Johnson,S.Prevention of Clostridium difficile Infection With Probiotics Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2015 ;60 Suppl 2:S122-8
Wieczorkiewicz,J. T.; Lopansri,B. K.; Cheknis,A.; Osmolski,J. R.; Hecht,D. W.; Gerding,D. N.; Johnson,S.Fluoroquinolone and Macrolide Exposure Predict Clostridium difficile Infection (CDI) with the Highly Fluoroquinolone- and Macrolide-Resistant Epidemic C. difficile Strain, BI/NAP1/027 Antimicrobial Agents and Chemotherapy 2015 ; :
Snydman,D. R.; McDermott,L. A.; Jacobus,N. V.; Thorpe,C.; Stone,S.; Jenkins,S. G.; Goldstein,E. J.; Patel,R.; Forbes,B. A.; Mirrett,S.; Johnson,S.; Gerding,D. N.A US Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile Associated Diarrheal Isolates and their Susceptibility to Fidaxomicin Antimicrobial Agents and Chemotherapy 2015 ;59(10):6437-6443
Qvarnstrom,Y.; Xayavong,M.; Aramburu da Silva,A. C.; Park,S. Y.; Whelen,A. C.; Calimlim,P. S.; Sciulli,R. H.; Honda,S. A.; Higa,K.; Kitsutani,P.; Chea,N.; Heng,S.; Johnson,S.; Graeff-Teixeira,C.; Fox,L. M.; da Silva,A. J.Real-Time Polymerase Chain Reaction Detection of Angiostrongylus cantonensis DNA in Cerebrospinal Fluid from Patients with Eosinophilic Meningitis The American Journal of Tropical Medicine and Hygiene 2015 ; :
Soriano,M. M.; Danziger,L. H.; Gerding,D. N.; Johnson,S.Novel Fidaxomicin Treatment Regimens for Patients With Multiple Clostridium difficile Infection Recurrences That Are Refractory to Standard Therapies Open forum infectious diseases 2014 ;1(2):ofu069
Gerding,D. N.; Johnson,S.; Rupnik,M.; Aktories,K.Clostridium difficile binary toxin CDT: mechanism, epidemiology, and potential clinical importance Gut microbes 2014 ;5(1):15-27
Balbale,S. N.; Johnson,S.; Burns,S. P.; Kralovic,S. M.; Goldstein,B.; Gerding,D. N.; Evans,C. T.Community-Associated Clostridium difficile Infection among Veterans with Spinal Cord Injury and Disorder Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2014 ;35(5):577-580
Bonchak,J. G.; Eby,J. M.; Willenborg,K. A.; Chrobak,D.; Henning,S. W.; Krzywiec,A.; Johnson,S. L.; Le Poole,I. C.Targeting melanocyte and melanoma stem cells by 8-hydroxy-2-dipropylaminotetralin ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS 2014 ;563:71-78
Manzo,C. E.; Merrigan,M. M.; Johnson,S.; Gerding,D. N.; Riley,T. V.; Silva,J.,Jr; Brazier,J. S.; International Clostridium difficile Study GroupInternational typing study of Clostridium difficile Anaerobe 2014 ;28:4-7
Ramanathan,S.; Johnson,S.; Burns,S. P.; Kralovic,S. M.; Goldstein,B.; Smith,B.; Gerding,D. N.; Evans,C. T.Recurrence of Clostridium difficile infection among veterans with spinal cord injury and disorder American Journal of Infection Control 2014 ;42(2):168-173
Johnson,S.Editorial commentary: Changing epidemiology of Clostridium difficile and emergence of new virulent strains Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014 ;58(12):1731-1733
Wang,M.; Johnson,S.Enteric infections Cancer treatment and research 2014 ;161:237-251
Johnson,S.; Louie,T. J.; Gerding,D. N.; Cornely,O. A.; Chasan-Taber,S.; Fitts,D.; Gelone,S. P.; Broom,C.; Davidson,D. M.; Polymer Alternative for CDI Treatment (PACT) investigatorsVancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2014 ;59(3):345-354
Wang,M. S.; Evans,C. T.; Rodriguez,T.; Gerding,D. N.; Johnson,S.Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancy Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2013 ;34(2):127-132
Pacheco,S. M.; Johnson,S.Important clinical advances in the understanding of Clostridium difficile infection CURRENT OPINION IN GASTROENTEROLOGY 2013 ;29(1):42-48
Gerding,D. N.; Johnson,S.Editorial Commentary: Does Infection With Specific Clostridium difficile Strains or Clades Influence Clinical Outcome? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013 ;56(11):1601-1603
Figueroa,I.; Johnson,S.; Sambol,S. P.; Goldstein,E. J.; Citron,D. M.; Gerding,D. N.Relapse versus reinfection: recurrent Clostridium difficile infection following treatment with fidaxomicin or vancomycin. Clinical Infectious Diseases 2012 ;55(Suppl 2):S104-9
Siddiqui,F.; O'Connor,J. R.; Nagaro,K.; Cheknis,A.; Sambol,S. P.; Vedantam,G.; Gerding,D. N.; Johnson,S.Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization. Journal of Infectious Diseases 2012 ;205(1):128-133
Petrella,L. A.; Sambol,S. P.; Cheknis,A.; Nagaro,K.; Kean,Y.; Sears,P. S.; Babakhani,F.; Johnson,S.; Gerding,D. N.Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain. Clinical Infectious Diseases 2012 ;55(3):351-357
Johnson,S.Meeting the challenge of recurrent Clostridium difficile infection Journal of Hospital Medicine 2012 ;7 Suppl 3:S11-3
Venugopal,A. A.; Gerding,D. N.; Johnson,S.Clostridium difficile infection rates and spectrum of disease among peripartum women at one hospital from 2003 to 2007 with molecular typing analysis of recovered Clostridium difficile isolates American Journal of Infection Control 2011 ;39(3):206-211
Gerding,D. N.; Johnson,StuartClostridium difficile infection in 2010: advances in pathogenesis, diagnosis and management of CDI Nature Reviews Gastroenterology & Hepatology 2011 ;8(2):67-68
Gerding,D. N.; Johnson,S.Management of Clostridium difficile infection: thinking inside and outside the box Clinical Infectious Diseases 2010 ;51(11):1306-1313
Merrigan,M.; Venugopal,A.; Mallozzi,M.; Roxas,B.; Viswanathan,V. K.; Johnson,S.; Gerding,D. N.; Vedantam,G.Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. Journal of Bacteriology 2010 ;192(19):4904-4911
Jabbar,U.; Leischner,J.; Kasper,D.; Gerber,R.; Sambol,S. P.; Parada,J. P.; Johnson,S.; Gerding,D. N.Effectiveness of alcohol-based hand rubs for removal of Clostridium difficile spores from hands. Infection Control & Hospital Epidemiology 2010 ;31(6):565-570
Cheknis,A. K.; Sambol,S. P.; Davidson,D. M.; Nagaro,K. J.; Mancini,M. C.; Hidalgo-Arroyo,G. A.; Brazier,J. S.; Johnson,S.; Gerding,D. N.Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007. Anaerobe 2009 ;15(6):230-233
Johnson,S.Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes Journal of Infection 2009 ;58(6):403-410
Johnson,S.; Schriever,C.; Patel,U.; Patel,T.; Hecht,D. W.; Gerding,D. N.Rifaximin Redux: treatment of recurrent Clostridium difficile infections with rifaximin immediately post-vancomycin treatment. Anaerobe 2009 ;15(6):290-291
Andrews,E. M.; Tsai,S. Y.; Johnson,S. C.; Farrer,J. R.; Wagner,J. P.; Kopen,G. C.; Kartje,G. L.Human adult bone marrow-derived somatic cell therapy results in functional recovery and axonal plasticity following stroke in the rat. Experimental neurology 2008 ;211(2):588-592
O'Connor,J. R.; Galang,M. A.; Sambol,S. P.; Hecht,D. W.; Vedantam,G.; Gerding,D. N.; Johnson,S.Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile. Antimicrobial Agents & Chemotherapy 2008 ;52(8):2813-2817
Edwards,C. L.; Bennett,G. G.; Wolin,K. Y.; Johnson,S.; Fowler,S.; Whitfield,K. E.; Askew,S.; MacKinnon,D.; McDougald,C.; Hubbard,R.; Wellington,C.; Feliu,M.; Robinson,E.Misestimation of peer tobacco use: understanding disparities in tobacco use Journal of the National Medical Association 2008 ;100(3):299-302
Belmares,J.; Gerding,D. N.; Parada,J. P.; Miskevics,S.; Weaver,F.; Johnson,S.Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring system.[see comment] Journal of Infection 2007 ;55(6):495-501
Johnson,S.; Schriever,C.; Galang,M.; Kelly,C. P.; Gerding,D. N.Interruption of recurrent Clostridium difficile-associated diarrhea episodes by serial therapy with vancomycin and rifaximin. Clinical Infectious Diseases 2007 ;44(6):846-848
Matsuoka,N.; Patki,A.; Tiwari,H. K.; Luke,A.; Wu,X.; Johnson,S. B.; Gregersen,P. K.; Allison,D. B.; Leibel,R. L.; Chung,W. K.Association of MC3R with body mass index in African Americans. International journal of body composition research 2007 ;5:123-130
Razaq,N.; Sambol,S.; Nagaro,K.; Zukowski,W.; Cheknis,A.; Johnson,S.; Gerding,D. N.Infection of hamsters with historical and epidemic BI types of Clostridium difficile. Journal of Infectious Diseases 2007 ;196(12):1813-1819
Chang,H. T.; Krezolek,D.; Johnson,S.; Parada,J. P.; Evans,C. T.; Gerding,D. N.Onset of symptoms and time to diagnosis of Clostridium difficile-associated disease following discharge from an acute care hospital. Infection Control & Hospital Epidemiology 2007 ;28(8):926-931
Hecht,D. W.; Galang,M. A.; Sambol,S. P.; Osmolski,J. R.; Johnson,S.; Gerding,D. N.In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004. Antimicrobial Agents & Chemotherapy 2007 ;51(8):2716-2719
Aboudola,S.; Sienko,A.; Carey,R. B.; Johnson,S.Tuberculous tenosynovitis. Human pathology 2004 ;35(8):1044-1046